NOE-105

· Noema Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NOE-105, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) [Phase 2]